
Opinion|Videos|September 30, 2023
Patient Scenario 1: 65-Year-old Woman with R/R Follicular Lymphoma
A panel of experts present that case of a 65-year-old woman with follicular lymphoma and discuss potential approaches for treatment in the relapsed or refractory setting.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Risvutatug Rezetecan Improves Overall Survival in Relapsed SCLC Trial
2
FDA OKs Pembrolizumab/EV Combo in Muscle Invasive Bladder Cancer
3
EMA’s Review of Daraxonrasib in PDAC Accelerated Under Phased Review Process
4
A Narrowing Definition of Unfit Populations in Frontline AML
5






![“[Epcoritamab/R2] is a good option for [patients] at first relapse or even further, even if they are very high risk,” said Benoit Tessoulin, MD, PhD.](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/d4c175d2fd9b443716f5ad06bfae7bc796a1795a-1200x1200.jpg?w=350&fit=crop&auto=format)























































